Psoriatic Inflammation Markers Predictive of Response to Adalimumab

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

November 30, 2019

Study Completion Date

June 18, 2020

Conditions

Psoriasis Vulgaris

Interventions

DIAGNOSTIC_TEST

cutaneous

SKIN BIOPSY

Trial Locations (1)

CHU Poitiers, Poitiers

All Listed Sponsors

lead

Poitiers University Hospital

OTHER

NCT03389984 - Psoriatic Inflammation Markers Predictive of Response to Adalimumab | Biotech Hunter | Biotech Hunter